PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAzzalure
Azzalure
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1250 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Muscle spasticityD009128——1374823
Overactive urinary bladderD053201EFO_1000781N32.81—493823
Urinary incontinenceD014549—R321263517
Migraine disordersD008881EFO_0003821G43——55616
StrokeD020521EFO_0000712I63.91342515
TorticollisD014103—F45.8—1—4611
HyperhidrosisD006945———11316
HeadacheD006261—R51——1135
DystoniaD004421—————145
BlepharospasmD001764—G24.5———134
Show 19 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cerebral palsyD002547—G80—15——5
Dystonic disordersD020821—G24—11—34
Myofascial pain syndromesD009209EFO_1001054—1—1——2
Shoulder painD020069—M25.51——1—12
ProstatitisD011472EFO_0003830N411—1——2
ArthritisD001168EFO_0005856M05-M14—11——2
ArthralgiaD018771—M25.5—11——2
Temporomandibular joint disordersD013705—M26.6——1——1
Facial painD005157—R51.9——1——1
AcrodyniaD000170EFO_1001756———1——1
Show 18 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OsteoarthritisD010003EFO_0002506M15-M1913———3
Prostatic hyperplasiaD011470EFO_0000284N4013———3
NeuralgiaD009437EFO_0009430——1——12
Magnetic resonance imagingD008279———1———1
TherapeuticsD013812———1———1
Joint diseasesD007592—M12.9—1———1
Hypertrophic cicatrixD017439—L91.0—1———1
PruritusD011537—L2911———1
Major depressive disorderD003865EFO_0003761F22—1———1
Carpal tunnel syndromeD002349EFO_0004143G56.0—1———1
Show 9 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Complex regional pain syndromesD020918EFO_1001998—1————1
Pelvic painD017699——1————1
DyspareuniaD004414—N94.11————1
VaginismusD052065—N94.21————1
PsoriasisD011565EFO_0000676L401————1
Chronic painD059350——1————1
Stress urinary incontinenceD014550——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Traumatic brain injuriesD000070642—S06————22
Herpes labialisD006560EFO_1001347B00.1————11
StrabismusD013285—H50.2————11
Diabetes mellitusD003920EFO_0000400E08-E13————11
Neck painD019547—M54.2————11
Back painD001416—M54————11
DysphoniaD055154—R49.0————11
Abnormal reflexD012021—R29.2————11
Muscle strengthD053580——————11
Clostridium botulinum type aD047013——————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
141 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use